BriaCell Therapeutics Corp.
@BriaCell • 5,818 subscribers
An immuno-oncology company developing targeted and effective immunotherapies for advanced breast cancer and other cancers. (Nasdaq: $BCTX, $BCTXW) (TSX: BCT)
Videos
BriaCell's registration-enabling pivotal Phase 3 study of its lead clinical candidate, Bria-IMT™, in combination with an immune check point inhibitor, is approved by the IRB & will soon enroll patients with advanced metastatic #breastcancer. $BCTX $BCTXW
BriaCell Therapeutics Corp.1,319,594 просмотров • 2 лет назад
Больше нет контента для загрузки